Δημοσιευμένη Έρευνα

Δημοσιεύσεις σε περιοδικά μετά από κρίση

1. Walker AR, Venetis CA, Opdahl S, Chambers GM, Jorm LR, Vajdic CM. Estimating the impact of bias in causal epidemiological studies: the case of health outcomes following assisted reproduction. Hum Reprod. 2024;39(5):869-75.

2. Feferkorn I, Santos-Ribeiro S, Ubaldi FM, Velasco JG, Ata B, Blockeel C, et al. Correction to: The HERA (Hyper‑response Risk Assessment) Delphi consensus for the management of hyper‑responders in in vitro fertilization. J Assist Reprod Genet. 2024;41(2):519-20.

3. Bayoumi RR, Hurt L, Zhang N, Law YJ, Venetis C, Fatem HM, et al. A critical systematic review and meta-analyses of risk factors for fertility problems in a globalized world. Reprod Biomed Online. 2024;48(3):103217.

4. Xiong T, Fraison E, Kolibianaki E, Costello MF, Venetis C, Kostova EB. Statins for women with polycystic ovary syndrome not actively trying to conceive. Cochrane Database Syst Rev. 2023;7(7):Cd008565.

5. Venetis CA, Storr A, Chua SJ, Mol BW, Longobardi S, Yin X, et al. What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis. Hum Reprod Update. 2023;29(3):307-26.

6. Venetis CA, Mol BW. Biosimilars versus the originator of follitropin alfa: Randomized controlled trials are still the best way to evaluate their comparative effectiveness in assisted reproduction. Drug Discov Today. 2023;28(2):103425.

7. Venetis CA, Helwig C, Mol BW, Chua SJ, Longobardi S, Orvieto R, et al. Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):68.

8. Venetis C, Keller E, Chambers GM. Freeze-all embryos during treatment with assisted reproduction: Health economic aspects. Best Pract Res Clin Obstet Gynaecol. 2023;86:102303.

9. Venetis C, Choi SKY, Jorm L, Zhang X, Ledger W, Lui K, et al. Risk for Congenital Anomalies in Children Conceived With Medically Assisted Fertility Treatment : A Population-Based Cohort Study. Ann Intern Med. 2023;176(10):1308-20.

10. McCredie S, An B, McShane M, Ledger WL, Venetis C. Serum anti-müllerian hormone (AMH) concentration during pregnancy: a longitudinal study. Reprod Fertil. 2023;4(2).

11. Iakovidou MC, Kolibianakis E, Zepiridis L, Venetis C. The role of endometrial scratching prior to in vitro fertilization: an updated systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):89.

12. Feferkorn I, Santos-Ribeiro S, Ubaldi FM, Velasco JG, Ata B, Blockeel C, et al. The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization. J Assist Reprod Genet. 2023;40(11):2681-95.

13. Eastick J, Venetis C, Cooke S, Chapman M. Detailed analysis of cytoplasmic strings in human blastocysts: new insights. Zygote. 2023;31(1):78-84.

14. Eastick J, Venetis C, Cooke S, Chapman M. Inter- and Intra-Observer Agreement Between Embryologists for Cytoplasmic String Assessment in Day 5/6 Human Blastocysts. Reprod Sci. 2023;30(6):1917-26.

15. Choi SKY, Lazzari E, Venetis C, Chambers GM. Childbirth timing and completed family size by the mode of conception-the role of medically assisted reproduction: a population-based cohort study in Australia. Lancet Reg Health West Pac. 2023;33:100686.

16. Wang R, McLernon DJ, Lai S, Showell MG, Chen ZJ, Wei D, et al. Individual participant data meta-analysis of trials comparing frozen versus fresh embryo transfer strategy (INFORM): a protocol. BMJ Open. 2022;12(7):e062578.

17. Venetis CA. Pro: Fresh versus frozen embryo transfer. Is frozen embryo transfer the future? Hum Reprod. 2022;37(7):1379-87.

18. Schwarze JE, Venetis C, Iniesta S, Falla E, Lukyanov V, de Agustin Calvo E, et al. Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers. Best Pract Res Clin Obstet Gynaecol. 2022;85(Pt B):203-16.

19. Liperis G, Fraire-Zamora JJ, Makieva S, Massarotti C, Ali ZE, Kohlhepp F, et al. #ESHREjc report: trick or treatment-evidence based use of add-ons in ART and patient perspectives. Hum Reprod. 2022;37(2):386-8.

20. Choi SKY, Venetis C, Ledger W, Havard A, Harris K, Norman RJ, et al. Population-wide contribution of medically assisted reproductive technologies to overall births in Australia: temporal trends and parental characteristics. Hum Reprod. 2022;37(5):1047-58.

21. An BGL, Chapman M, Tilia L, Venetis C. Is there an optimal window of time for transferring single frozen-thawed euploid blastocysts? A cohort study of 1170 embryo transfers. Hum Reprod. 2022;37(12):2797-807.

22. Zhang N, Law YJ, Venetis CA, Chambers GM, Harris K. Female age is associated with the optimal number of oocytes to maximize fresh live birth rates: an analysis of 256,643 fresh ART cycles. Reprod Biomed Online. 2021;42(3):669-78.

23. Venetis CA. Endometrial injury before IVF: light at the end of the tunnel or false hope? Hum Reprod. 2021;36(1):1-2.

24. Tarlatzi T, Venetis C, Sassi A, Devreker F, Englert Y, Delbaere A. Higher estradiol levels are associated with lower neonatal birthweight after fresh and frozen embryo transfers. A cohort study of 3631 singleton IVF pregnancies. Gynecol Endocrinol. 2021;37(7):618-23.

25. Orvieto R, Venetis CA, Fatemi HM, D’Hooghe T, Fischer R, Koloda Y, et al. Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus. Front Endocrinol (Lausanne). 2021;12:675670.

26. Law YJ, Zhang N, Kolibianakis EM, Costello MF, Keller E, Chambers GM, et al. Is there an optimal number of oocytes retrieved at which live birth rates or cumulative live birth rates per aspiration are maximized after ART? A systematic review. Reprod Biomed Online. 2021;42(1):83-104.

27. Eastick J, Venetis C, Cooke S, Chapman M. The presence of cytoplasmic strings in human blastocysts is associated with the probability of clinical pregnancy with fetal heart. J Assist Reprod Genet. 2021;38(8):2139-49.

28. Chua SJ, Mol BW, Longobardi S, Orvieto R, Venetis CA, Lispi M, et al. Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2021;19(1):51.

29. Chambers GM, Choi SKY, Irvine K, Venetis C, Harris K, Havard A, et al. A bespoke data linkage of an IVF clinical quality registry to population health datasets; methods and performance. Int J Popul Data Sci. 2021;6(1):1679.

30. Venetis CA. Monozygotic twinning after PGT: methodological considerations. Bjog. 2020;127(5):570.

31. Venetis C, d’Hooghe T, Barnhart KT, Bossuyt PMM, Mol BWJ. Methodologic considerations in randomized clinical trials in reproductive medicine. Fertil Steril. 2020;113(6):1107-12.

32. Tilia L, Chapman M, Kilani S, Cooke S, Venetis C. Oocyte meiotic spindle morphology is a predictive marker of blastocyst ploidy-a prospective cohort study. Fertil Steril. 2020;113(1):105-13.e1.

33. Paul RC, Fitzgerald O, Lieberman D, Venetis C, Chambers GM. Cumulative live birth rates for women returning to ART treatment for a second ART-conceived child. Hum Reprod. 2020;35(6):1432-40.

34. Lainas GT, Lainas TG, Sfontouris IA, Venetis CA, Kyprianou MA, Petsas GK, et al. A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCG. Hum Reprod Open. 2020;2020(3):hoaa013.

35. Lainas GT, Lainas TG, Sfontouris IA, Venetis CA, Bosdou JK, Chatzimeletiou A, et al. Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study. Reprod Biomed Online. 2020;40(1):168-75.

36. Karatasiou GI, Bosdou JK, Venetis CA, Zepiridis L, Chatzimeletiou K, Tarlatzi TB, et al. Is the probability of pregnancy after ovarian stimulation for IVF associated with serum estradiol levels on the day of triggering final oocyte maturation with hCG? A systematic review and meta-analysis. J Assist Reprod Genet. 2020;37(7):1531-41.

37. Glanville EJ, Venetis C, Boothroyd CA, Farquhar C, Hull ML. The use of oil-soluble contrast media for tubal flushing in infertility: A consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence). Aust N Z J Obstet Gynaecol. 2020;60(5):667-70.

38. Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;8(8):Cd005552.

39. Chambers GM, Venetis CA, Jorm LR, Stavrou EP, Vajdic CM. Parity: A key measure of confounding in data-linkage studies of outcomes after medically assisted reproduction. Int J Popul Data Sci. 2020;5(1):1119.

40. Vermey BG, Chua SJ, Zafarmand MH, Wang R, Longobardi S, Cottell E, et al. Is there an association between oocyte number and embryo quality? A systematic review and meta-analysis. Reprod Biomed Online. 2019;39(5):751-63.

41. Vermey BG, Buchanan A, Chambers GM, Kolibianakis EM, Bosdou J, Chapman MG, et al. Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis. Bjog. 2019;126(2):209-18.

42. Venetis CA, Tilia L, Panlilio E, Kan A. Is more better? A higher oocyte yield is independently associated with more day-3 euploid embryos after ICSI. Hum Reprod. 2019;34(1):79-83.

43. Venetis CA. Physical activity in pregnancy and offspring weight: what we know and what we don’t. Bjog. 2019;126(4):471.

44. Storr A, Bilir E, Cooke S, Garrett D, Venetis CA. Fine-tuning blastocyst selection based on morphology: a multicentre analysis of 2461 single blastocyst transfers. Reprod Biomed Online. 2019;39(4):588-98.

45. Lensen S, Venetis C, Ng EHY, Young SL, Vitagliano A, Macklon NS, et al. Should we stop offering endometrial scratching prior to in vitro fertilization? Fertil Steril. 2019;111(6):1094-101.

46. Law YJ, Zhang N, Venetis CA, Chambers GM, Harris K. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles. Hum Reprod. 2019;34(9):1778-87.

47. Lainas GT, Lainas TG, Sfontouris IA, Chatzimeletiou K, Venetis CA, Bosdou JK, et al. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome? Hum Reprod. 2019;34(9):1770-7.

48. Costello MF, Garad RM, Hart R, Homer H, Johnson L, Jordan C, et al. A Review of Second- and Third-line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome. Med Sci (Basel). 2019;7(7).

49. Costello M, Garad R, Hart R, Homer H, Johnson L, Jordan C, et al. A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome. Med Sci (Basel). 2019;7(9).

50. Bosdou JK, Venetis CA, Tarlatzis BC, Grimbizis GF, Kolibianakis EM. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis. Hum Reprod. 2019;34(3):491-505.

51. Venetis CA, Tarlatzis BC. Trying to define the optimal progesterone elevation cut-off in fresh in vitro fertilization cycles: time to evolve our way of thinking. Fertil Steril. 2018;110(4):634-5.

52. Venetis CA, Mol BW, Kolibianakis EM. Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? Hum Reprod. 2018;33(12):2312-3.

53. Storr A, Venetis C, Cooke S, Kilani S, Ledger W. Time-lapse algorithms and morphological selection of day-5 embryos for transfer: a preclinical validation study. Fertil Steril. 2018;109(2):276-83.e3.

54. Sfontouris I, Lainas G, Lainas T, Venetis C, Makris A, Tarlatzis B, et al. OC05: Ultrasound and hematological early-luteal-phase predictors of severe ovarian hyperstimulation syndrome in high-risk patients following triggering of final oocyte maturation with human chorionic gonadotropin. Ultrasound Obstet Gynecol. 2018;52(4):556.

55. Mol BW, Bossuyt PM, Sunkara SK, Garcia Velasco JA, Venetis C, Sakkas D, et al. Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients. Fertil Steril. 2018;109(6):968-79.

56. Lainas GT, Lainas TG, Venetis CA, Sfontouris IA, Zorzovilis IZ, Alexopoulou E, et al. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome. Ultrasound Obstet Gynecol. 2018;51(1):126-33.

57. Kolibianakis EM, Griesinger G, Venetis CA. GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions. Hum Reprod Update. 2018;24(2):242-3.

58. Tarlatzi TB, Venetis CA, Devreker F, Englert Y, Delbaere A. What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study. J Assist Reprod Genet. 2017;34(10):1341-51.

59. Tarlatzi TB, Imbert R, Alvaro Mercadal B, Demeestere I, Venetis CA, Englert Y, et al. Does oocyte donation compared with autologous oocyte IVF pregnancies have a higher risk of preeclampsia? Reprod Biomed Online. 2017;34(1):11-8.

60. Storr A, Venetis CA, Cooke S, Kilani S, Ledger W. Inter-observer and intra-observer agreement between embryologists during selection of a single Day 5 embryo for transfer: a multicenter study. Hum Reprod. 2017;32(2):307-14.

61. Sfontouris IA, Kolibianakis EM, Lainas GT, Venetis CA, Petsas GK, Tarlatzis BC, et al. Blastocyst utilization rates after continuous culture in two commercial single-step media: a prospective randomized study with sibling oocytes. J Assist Reprod Genet. 2017;34(10):1377-83.

62. McCredie S, Ledger W, Venetis CA. Anti-Müllerian hormone kinetics in pregnancy and post-partum: a systematic review. Reprod Biomed Online. 2017;34(5):522-33.

63. Lensen S, Jordan V, Showell M, Showell E, Shen V, Venetis C, et al. Non-publication and publication bias in reproductive medicine: a cohort analysis. Hum Reprod. 2017;32(8):1658-66.

64. Eastick J, Venetis C, Cooke S, Storr A, Susetio D, Chapman M. Is early embryo development as observed by time-lapse microscopy dependent on whether fresh or frozen sperm was used for ICSI? A cohort study. J Assist Reprod Genet. 2017;34(6):733-40.

65. Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, et al. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles. Hum Reprod. 2016;31(8):1859-65.

66. Tilia L, Venetis C, Kilani S, Cooke S, Chapman M. Is oocyte meiotic spindle morphology associated with embryo ploidy? A prospective cohort study. Fertil Steril. 2016;105(4):1085-92.e7.

67. Sumner P, Vivian-Griffiths S, Boivin J, Williams A, Bott L, Adams R, et al. Exaggerations and Caveats in Press Releases and Health-Related Science News. PLoS One. 2016;11(12):e0168217.

68. Kolibianakis EM, Lainas TG, Venetis CA. Reply: Modified natural cycles for poor responders: addressing misconceptions and fallacies. Hum Reprod. 2016;31(1):222-3.

69. Gameiro S, Boivin J, Dancet E, Emery M, Thorn P, Van den Broeck U, et al. Qualitative research in the ESHRE Guideline ‘Routine psychosocial care in infertility and medically assisted reproduction – a guide for staff’. Hum Reprod. 2016;31(8):1928-9.

70. Bosdou JK, Venetis CA, Dafopoulos K, Zepiridis L, Chatzimeletiou K, Anifandis G, et al. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial. Hum Reprod. 2016;31(5):977-85.

71. Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod. 2015;30(3):684-91.

72. Storr A, Venetis CA, Cooke S, Susetio D, Kilani S, Ledger W. Morphokinetic parameters using time-lapse technology and day 5 embryo quality: a prospective cohort study. J Assist Reprod Genet. 2015;32(7):1151-60.

73. Skolarikos A, Grivas N, Kallidonis P, Mourmouris P, Rountos T, Fiamegos A, et al. The Efficacy of Medical Expulsive Therapy (MET) in Improving Stone-free Rate and Stone Expulsion Time, After Extracorporeal Shock Wave Lithotripsy (SWL) for Upper Urinary Stones: A Systematic Review and Meta-analysis. Urology. 2015;86(6):1057-64.

74. Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, et al. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Hum Reprod. 2015;30(10):2321-30.

75. Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, et al. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial. Hum Reprod. 2015;30(2):432-40.

76. Griesinger G, Venetis CA, Tarlatzis B, Kolibianakis EM. To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already! Reprod Biomed Online. 2015;31(1):6-8.

77. Goutziomitrou E, Venetis CA, Kolibianakis EM, Bosdou JK, Parlapani A, Grimbizis G, et al. Propofol versus thiopental sodium as anaesthetic agents for oocyte retrieval: a randomized controlled trial. Reprod Biomed Online. 2015;31(6):752-9.

78. Gameiro S, Boivin J, Dancet E, de Klerk C, Emery M, Lewis-Jones C, et al. ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction-a guide for fertility staff. Hum Reprod. 2015;30(11):2476-85.

79. Bosdou JK, Kolibianakis EM, Venetis CA, Zepiridis L, Chatzimeletiou K, Makedos A, et al. Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate? Reprod Biomed Online. 2015;31(5):625-32.

80. Athanatos D, Pados G, Venetis CA, Stamatopoulos P, Rousso D, Tsolakidis D, et al. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial. Clin Exp Obstet Gynecol. 2015;42(3):347-51.

81. Venetis CA, Papadopoulos SP, Campo R, Gordts S, Tarlatzis BC, Grimbizis GF. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online. 2014;29(6):665-83.

82. Venetis CA. The Bologna criteria for poor ovarian response: the good, the bad and the way forward. Hum Reprod. 2014;29(9):1839-41.

83. Sumner P, Vivian-Griffiths S, Boivin J, Williams A, Venetis CA, Davies A, et al. The association between exaggeration in health related science news and academic press releases: retrospective observational study. Bmj. 2014;349:g7015.

84. Mintziori G, Goulis DG, Gialamas E, Dosopoulos K, Zouzoulas D, Gitas G, et al. Association of TSH concentrations and thyroid autoimmunity with IVF outcome in women with TSH concentrations within normal adult range. Gynecol Obstet Invest. 2014;77(2):84-8.

85. Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol. 2014;12:17.

86. Ganidou MA, Kolibianakis EM, Venetis CA, Gerou S, Makedos GA, Klearchou N, et al. Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study. Gynecol Endocrinol. 2014;30(11):817-21.

87. Balli EP, Venetis CA, Miyakis S. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Antimicrob Agents Chemother. 2014;58(2):734-9.

88. Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update. 2013;19(5):433-57.

89. Bili E, Venetis C, Athanatos D, Tsolakidis D, Assimakopoulos E, Tarlatzis B. Galanin in the amniotic fluid and neonatal birth weight: a prospective observational study. J Matern Fetal Neonatal Med. 2013;26(13):1316-20.

90. Zorba E, Vavilis D, Venetis CA, Zournatzi V, Kellartzis D, Tarlatzis BC. Visfatin serum levels are increased in women with preeclampsia: a case-control study. J Matern Fetal Neonatal Med. 2012;25(9):1668-73.

91. Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis. Curr Pharm Biotechnol. 2012;13(3):464-70.

92. Kolibianakis EM, Griesinger G, Venetis CA. GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum Reprod Update. 2012;18(2):228-9; author reply 9-30.

93. Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L, et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(2):127-45.

94. Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Papadimas I, Tarlatzis BC. Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(1):188-96, 96.e1-3.

95. Mintziori G, Goulis DG, Toulis KA, Venetis CA, Kolibianakis EM, Tarlatzis BC. Thyroid function during ovarian stimulation: a systematic review. Fertil Steril. 2011;96(3):780-5.

96. Kolibianakis EM, Venetis CA, Tarlatzis BC. DHEA administration in poor responders. Hum Reprod. 2011;26(3):730-1; author reply 1.

97. Kolibianakis EM, Venetis CA, Kalogeropoulou L, Papanikolaou E, Tarlatzis BC. Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial. Fertil Steril. 2011;95(2):558-62.

98. Dafopoulos K, Venetis C, Messini CI, Pournaras S, Anifandis G, Garas A, et al. Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone. Reprod Biol Endocrinol. 2011;9:59.

99. Boivin J, Griffiths E, Venetis CA. Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies. Bmj. 2011;342:d223.

100. Venetis CA, Kolibianakis EM, Tarlatzi TB, Tarlatzis BC. Evidence-based management of poor ovarian response. Ann N Y Acad Sci. 2010;1205:199-206.

101. Tsitlakidis A, Foroglou N, Venetis CA, Patsalas I, Hatzisotiriou A, Selviaridis P. Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis. J Neurosurg. 2010;112(5):1020-32.

102. Toulis KA, Iliadou PK, Venetis CA, Tsametis C, Tarlatzis BC, Papadimas I, et al. Inhibin B and anti-Mullerian hormone as markers of persistent spermatogenesis in men with non-obstructive azoospermia: a meta-analysis of diagnostic accuracy studies. Hum Reprod Update. 2010;16(6):713-24.

103. Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Negro R, Tarlatzis BC, et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol. 2010;162(4):643-52.

104. Papanikolaou EG, Fatemi H, Venetis C, Donoso P, Kolibianakis E, Tournaye H, et al. Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertil Steril. 2010;93(2):592-7.

105. Pados G, Venetis CA, Almaloglou K, Tarlatzis BC. Prevention of intra-peritoneal adhesions in gynaecological surgery: theory and evidence. Reprod Biomed Online. 2010;21(3):290-303.

106. Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril. 2010;94(6):2382-4.

107. Venetis CA, Kolibianakis EM, Tarlatzi TB, Tarlatzis BC. Benefits of luteinizing hormone activity in ovarian stimulation for IVF. Reprod Biomed Online. 2009;18 Suppl 2:31-6.

108. Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Tarlatzis BC, Papadimas I. Thyroid autoimmunity and miscarriages: the corpus luteum hypothesis. Med Hypotheses. 2009;73(6):1060-2.

109. Toulis KA, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC, Papadimas I. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril. 2009;92(2):667-77.

110. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91(3):749-66.

111. Kyrou D, Kolibianakis EM, Venetis CA, Miliaras D, Theodoridis T, Tzevelekis F, et al. Steroid receptor expression in human endometrium during the follicular phase of stimulated cycles. Hum Reprod. 2009;24(11):2931-5.

112. Kolibianakis EM, Venetis CA, Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: which one is better? Curr Opin Obstet Gynecol. 2009;21(3):270-4.

113. Kolibianakis EM, Venetis CA, Tarlatzis BC. Role of the endocrine profile for the achievement of pregnancy with IVF. Reprod Biomed Online. 2009;18 Suppl 2:37-43.

114. Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009;15(6):613-22.

115. Devroey P, Fauser BC, Diedrich K. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update. 2009;15(4):391-408.

116. Venetis CA, Kolibianakis EM, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: facts and fiction. Hum Reprod Update. 2008;14(5):538.

117. Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, et al. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod. 2008;23(1):91-9.

118. Loutradi KE, Kolibianakis EM, Venetis CA, Papanikolaou EG, Pados G, Bontis I, et al. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril. 2008;90(1):186-93.

119. Kolibianakis EM, Venetis CA, Papanikolaou EG, Diedrich K, Tarlatzis BC, Griesinger G. Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis. Hum Reprod. 2008;23(6):1346-54.

120. Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC, Kolibianakis EM. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril. 2008;90(4):1055-63.

121. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update. 2007;13(4):343-55.

122. Kolibianakis EM, Venetis CA, Tarlatzis BC. The effect of oral contraceptives on assisted reproductive technology [corrected] cycles. Curr Opin Obstet Gynecol. 2007;19(3):244-7.